BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 11027299)

  • 1. A conserved mechanism of retrovirus restriction in mammals.
    Towers G; Bock M; Martin S; Takeuchi Y; Stoye JP; Danos O
    Proc Natl Acad Sci U S A; 2000 Oct; 97(22):12295-9. PubMed ID: 11027299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single amino acid changes in the murine leukemia virus capsid protein gene define the target of Fv1 resistance.
    Kozak CA; Chakraborti A
    Virology; 1996 Nov; 225(2):300-5. PubMed ID: 8918916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation and characterization of a stable full-length ecotropic murine leukemia virus molecular clone that produces novel phenotypes to Fv1 restriction.
    Bae EH; Park SH; Park SM; Park JW; Lim MS; Jung YT
    J Microbiol Biotechnol; 2008 Apr; 18(4):799-804. PubMed ID: 18467880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-entry restriction of retroviral infections.
    Towers GJ; Goff SP
    AIDS Rev; 2003; 5(3):156-64. PubMed ID: 14598564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of the regions of Fv1 necessary for murine leukemia virus restriction.
    Bishop KN; Bock M; Towers G; Stoye JP
    J Virol; 2001 Jun; 75(11):5182-8. PubMed ID: 11333899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of N-tropic mutant porcine endogenous retrovirus infectivity by human tripartite motif-containing 5-isoform alpha.
    Lee J; Cho YD; Heo YK; Kwon Y; Kim DG; Choi BS; Kim SS; Kim YB
    Transplant Proc; 2011 Sep; 43(7):2774-8. PubMed ID: 21911161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complex determinants within the Moloney murine leukemia virus capsid modulate susceptibility of the virus to Fv1 and Ref1-mediated restriction.
    Ulm JW; Perron M; Sodroski J; C Mulligan R
    Virology; 2007 Jul; 363(2):245-55. PubMed ID: 17343889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression levels of Fv1: effects on retroviral restriction specificities.
    Li W; Yap MW; Voss V; Stoye JP
    Retrovirology; 2016 Jun; 13(1):42. PubMed ID: 27342974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific packaging of spliced retroviral vector transcripts lacking the Psi-region.
    Pambalk K; Hohenadl C; Salmons B; Günzburg WH; Renner M
    Biochem Biophys Res Commun; 2002 Apr; 293(1):239-46. PubMed ID: 12054590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolution of the retroviral restriction gene Fv1: inhibition of non-MLV retroviruses.
    Yap MW; Colbeck E; Ellis SA; Stoye JP
    PLoS Pathog; 2014 Mar; 10(3):e1003968. PubMed ID: 24603659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic reshuffling reconstitutes functional expression cassettes in retroviral vectors.
    Tabotta W; Klein D; Hohenadl C; Salmons B; Günzburg WH
    J Gene Med; 2001; 3(5):418-26. PubMed ID: 11601755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retroviral restriction factors Fv1 and TRIM5alpha act independently and can compete for incoming virus before reverse transcription.
    Passerini LD; Keckesova Z; Towers GJ
    J Virol; 2006 Mar; 80(5):2100-5. PubMed ID: 16474118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fv1-like restriction of N-tropic replication-competent murine leukaemia viruses in mCAT-1-expressing human cells.
    Aagaard L; Mikkelsen JG; Warming S; Duch M; Pedersen FS
    J Gen Virol; 2002 Feb; 83(Pt 2):439-442. PubMed ID: 11807237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retroviral capsid determinants of Fv1 NB and NR tropism.
    Stevens A; Bock M; Ellis S; LeTissier P; Bishop KN; Yap MW; Taylor W; Stoye JP
    J Virol; 2004 Sep; 78(18):9592-8. PubMed ID: 15331691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positional cloning of the mouse retrovirus restriction gene Fv1.
    Best S; Le Tissier P; Towers G; Stoye JP
    Nature; 1996 Aug; 382(6594):826-9. PubMed ID: 8752279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rhesus monkey model for fetal gene transfer: studies with retroviral- based vector systems.
    Tarantal AF; O'Rourke JP; Case SS; Newbound GC; Li J; Lee CI; Baskin CR; Kohn DB; Bunnell BA
    Mol Ther; 2001 Feb; 3(2):128-38. PubMed ID: 11237669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consensus structural models for the amino terminal domain of the retrovirus restriction gene Fv1 and the murine leukaemia virus capsid proteins.
    Taylor WR; Stoye JP
    BMC Struct Biol; 2004 Jan; 4():1. PubMed ID: 14715087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lentiviral vectors pseudotyped with murine ecotropic envelope: increased biosafety and convenience in preclinical research.
    Schambach A; Galla M; Modlich U; Will E; Chandra S; Reeves L; Colbert M; Williams DA; von Kalle C; Baum C
    Exp Hematol; 2006 May; 34(5):588-92. PubMed ID: 16647564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cloning of a new murine endogenous retrovirus, MuERV-L, with strong similarity to the human HERV-L element and with a gag coding sequence closely related to the Fv1 restriction gene.
    Bénit L; De Parseval N; Casella JF; Callebaut I; Cordonnier A; Heidmann T
    J Virol; 1997 Jul; 71(7):5652-7. PubMed ID: 9188643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of murine leukemia virus restriction in mammals.
    Besnier C; Ylinen L; Strange B; Lister A; Takeuchi Y; Goff SP; Towers GJ
    J Virol; 2003 Dec; 77(24):13403-6. PubMed ID: 14645596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.